Waters' Q2 Revenues Increase 14 Percent but Miss Analyst Estimates

Despite the increase in revenues, company officials cited soft government and academic sales, pharma demand that tailed off as the quarter came to a close, and higher than expected SG&A expenses.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories